{"title":"Talk to Patients About: Vaccine Testing.","authors":"Sean Price","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The COVID-19 vaccines currently under production are expected to reach the public faster than any previous vaccine. But no matter how quickly a vaccine is produced, it still must pass a series of rigorous scientific tests before the U.S. Food and Drug Administration (FDA) will license it for public use.</p>","PeriodicalId":39209,"journal":{"name":"Texas Medicine","volume":"116 11","pages":"23"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Texas Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The COVID-19 vaccines currently under production are expected to reach the public faster than any previous vaccine. But no matter how quickly a vaccine is produced, it still must pass a series of rigorous scientific tests before the U.S. Food and Drug Administration (FDA) will license it for public use.
期刊介绍:
Texas Medicine is available to TMA members and presents timely information on public health, medicolegal issues, medical economics, science, medical education, and legislative affairs affecting Texas physicians and their patients.